Combined Cardiopulmonary Failure in COPD: SPIROMICS HF
Combined Cardiopulmonary Failure in COPD: SPIROMICS HF
批准号:
10020427
负责人:
R Graham BARR
金额:
$233.13万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-28 至 2024-06-30
关键词:
AdultAffectApicalBlood flowCardiacCardiac OutputCardiopulmonaryChronic Obstructive Airway DiseaseCodeComplexDRD1 geneDeath RateDevelopmental GeneDiffuseDimensionsDropsEFRACEchocardiographyEndotheliumExerciseFGF10 geneFailureFibrosisFunctional disorderFundingGasesGenesGoldHeartHeart AtriumHeart failureHospitalizationImpairmentKineticsLungLung CAT ScanMachine LearningMagnetic Resonance ImagingMeasuresMechanicsMethodsMolecularMulti-Ethnic Study of AtherosclerosisMyocardialNational Heart, Lung, and Blood InstituteOutcome MeasureParticipantPathologyPatientsPhenotypeProspective StudiesPulmonary EmphysemaPulmonary FibrosisPulmonary Heart DiseasePulmonary artery structureRARA geneRespiratory FailureRight Ventricular HypertrophyRight ventricular structureSamplingSmokerStructureSuggestionTechnologyTestingVariantVentricularWorkbasecardiogenesiscohortdisorder controldisorder subtypegenetic variantheart functionheart preservationindexinginnovationinterstitiallung hypoxianovelnovel diagnosticsnovel therapeutic interventionpatient subsetspersonalized approachpersonalized diagnosticspersonalized medicinepreservationpressurereceptorrecruittargeted treatmentunsupervised learningvasoconstriction
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The death rate and hospitalizations from chronic obstructive pulmonary disease (COPD) have doubled in the
last 50 years. A third of COPD hospitalizations overlap with heart failure, mostly with preserved ejection
fraction (HFpEF), yet no large COPD study has ascertained cardiac function. The Multi-Ethnic Study of
Atherosclerosis (MESA) COPD Study was funded to test the endothelial hypothesis of emphysema and
examine reduced RV dimensions (“cor pulmonale parvus”) in COPD. In the MESA COPD Study II, we found
that associations of reduced pulmonary microvascular blood flow with emphysema do not appear to be
confounded by hypoxic pulmonary vasoconstriction and that emphysema on CT predicted RV regression over
5 years. We also developed methods to further subtype emphysema and COPD and scaled them up to the
SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS). We used unsupervised
machine learning to discover new emphysema subtypes that are common and have molecular origins.
Separately, we found that 26% of adults have segmental airway variants, which are associated with COPD and
the developmental genes FGF10 and RARA. Both genes affect right heart development. In pilot work, we
found one dramatically altered RV strain and the other associated with cor pulmonale parvus. Finally, we
found that bronchitic ‘symptomatic smokers,’ who have hyperinflation from gas trapping, may have increased
LV diastolic dysfunction. Hence, cardiac alterations in COPD are complex but recent advances in COPD
subtyping may allow their personalized diagnosis and treatment. SPIROMICS is an NHLBI-funded prospective
study that recruited smokers with COPD and controls and is re-examining 2,000 participants with gold-
standard lung phenotyping including full-lung CT. We propose to add comprehensive echocardiography (echo)
with speckle-tracking for cardiac mechanics for 1,000 SPIROMICS participants, with exercise in 700 and
cardiopulmonary MRI in 600, to test the following hypotheses: 1) machine-learned subtypes of emphysema on
CT are associated with specific alterations in cardiac structure and function, which vary from cor pulmonale to
LV diastolic dysfunction; 2) participants with segmental airway variants have abnormal RV structure and
function; 3) symptomatic smokers have signs of increased LV afterload and LV diastolic dysfunction.
Innovative aspects of the application include the use of novel echo and MRI measures in a large, well-
characterized cohort of COPD patients. Confirmation of the hypotheses would define the mechanisms of
HFpEF in COPD and identify subsets of patients for targeted treatment of cardiopulmonary dysfunction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Training Program in Population Science of Respiratory Diseases
-
批准号:10469316
-
项目类别:
-
资助金额:$8.08万
-
财政年份:2019
-
负责人:R Graham BARR
-
依托单位:
Training Program in Population Science of Respiratory Diseases
-
批准号:10206247
-
项目类别:
-
资助金额:$8.92万
-
财政年份:2019
-
负责人:R Graham BARR
-
依托单位:
Training Program in Population Science of Respiratory Diseases
-
批准号:10671638
-
项目类别:
-
资助金额:$19.26万
-
财政年份:2019
-
负责人:R Graham BARR
-
依托单位:
Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS
-
批准号:10225220
-
项目类别:
-
资助金额:$80.63万
-
财政年份:2014
-
负责人:R Graham BARR
-
依托单位:
Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS
-
批准号:8894583
-
项目类别:
-
资助金额:$43.36万
-
财政年份:2014
-
负责人:R Graham BARR
-
依托单位:
Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS
-
批准号:10160645
-
项目类别:
-
资助金额:$73.03万
-
财政年份:2014
-
负责人:R Graham BARR
-
依托单位:
Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS
-
批准号:9927683
-
项目类别:
-
资助金额:$72.59万
-
财政年份:2014
-
负责人:R Graham BARR
-
依托单位:
Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS
-
批准号:10453736
-
项目类别:
-
资助金额:$72.83万
-
财政年份:2014
-
负责人:R Graham BARR
-
依托单位:
Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS
-
批准号:8759952
-
项目类别:
-
资助金额:$45.59万
-
财政年份:2014
-
负责人:R Graham BARR
-
依托单位:
HDL cholesterol and chronic lower respiratory disease events in five cohorts
-
批准号:8735184
-
项目类别:
-
资助金额:$11.76万
-
财政年份:2013
-
负责人:R Graham BARR
-
依托单位:
HDL cholesterol and chronic lower respiratory disease events in five cohorts
-
批准号:8624969
-
项目类别:
-
资助金额:$11.42万
-
财政年份:2013
-
负责人:R Graham BARR
-
依托单位:
Genome-wide and Linkage Study of Quantitative Emphysema Phenotypes
-
批准号:7833115
-
项目类别:
-
资助金额:$49.99万
-
财政年份:2009
-
负责人:R Graham BARR
-
依托单位:
Genome-wide and Linkage Study of Quantitative Emphysema Phenotypes
-
批准号:7935319
-
项目类别:
-
资助金额:$47.06万
-
财政年份:2009
-
负责人:R Graham BARR
-
依托单位:
Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary Disease (COPD)
-
批准号:7895734
-
项目类别:
-
资助金额:$75.51万
-
财政年份:2008
-
负责人:R Graham BARR
-
依托单位:
Pulmonary Microvascular Blood Flow and Cor Pulmonale Parvus in Emphysema/COPD
-
批准号:8794453
-
项目类别:
-
资助金额:$74.66万
-
财政年份:2008
-
负责人:R Graham BARR
-
依托单位:
Combined Cardiopulmonary Failure in COPD: SPIROMICS HF
-
批准号:10656151
-
项目类别:
-
资助金额:$197.17万
-
财政年份:2008
-
负责人:R Graham BARR
-
依托单位:
Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary Disease (COPD)
-
批准号:8126218
-
项目类别:
-
资助金额:$78.54万
-
财政年份:2008
-
负责人:R Graham BARR
-
依托单位:
Pulmonary Microvascular Blood Flow and Cor Pulmonale Parvus in Emphysema/COPD
-
批准号:8998971
-
项目类别:
-
资助金额:$77.86万
-
财政年份:2008
-
负责人:R Graham BARR
-
依托单位:
Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary Disease (COPD)
-
批准号:7682968
-
项目类别:
-
资助金额:$72.24万
-
财政年份:2008
-
负责人:R Graham BARR
-
依托单位:
Pulmonary Microvascular Blood Flow and Cor Pulmonale Parvus in Emphysema/COPD
-
批准号:9212177
-
项目类别:
-
资助金额:$69.66万
-
财政年份:2008
-
负责人:R Graham BARR
-
依托单位:
海外基金